Randomized Therapeutic Study Assessing the Superiority of a Sequential Intravenous Thrombolysis Treatment (Rt-PA + Tenecteplase) in Comparison With Rt-PA Standard Treatment in Proximal Middle Cerebral Artery Occlusion (DIVA).

Trial Profile

Randomized Therapeutic Study Assessing the Superiority of a Sequential Intravenous Thrombolysis Treatment (Rt-PA + Tenecteplase) in Comparison With Rt-PA Standard Treatment in Proximal Middle Cerebral Artery Occlusion (DIVA).

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 30 Sep 2016

At a glance

  • Drugs Tenecteplase (Primary) ; Alteplase
  • Indications Arterial occlusive disorders; Cerebrovascular disorders
  • Focus Therapeutic Use
  • Acronyms DIVA
  • Most Recent Events

    • 22 Sep 2016 Planned End Date changed from 1 Jul 2017 to 1 Mar 2018.
    • 22 Sep 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2017.
    • 22 Sep 2016 Planned initiation date changed from 1 Apr 2015 to 1 Nov 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top